Skip to content
Home » Japan’s largest app for atopic dermatitis patients, “Atopiyo”, has been selected for the world’s top accelerator “Berkeley SKYDECK”! ~To be released in the US~

Japan’s largest app for atopic dermatitis patients, “Atopiyo”, has been selected for the world’s top accelerator “Berkeley SKYDECK”! ~To be released in the US~

Japan’s largest app for atopic dermatitis patients, “Atopiyo”, has been selected for the world’s top accelerator “Berkeley SKYDECK”! ~To be released in the US~
*Atopiyo*
Press release: September 12, 2024
**
Japan’s largest app for atopic dermatitis patients, “Atopiyo”, has been selected for the world’s top accelerator “Berkeley SKYDECK”! ~To be released in the US~
BerkekeySKYDECK selected – Atopiyo

Atopiyo LLC (Location: Ichikawa City, Chiba Prefecture, Representative: Ako Ryotaro) is a member of Berkeley, a world-class acceleration program originating from the University of California, Berkeley.
We would like to inform you that our application has been adopted by “SKYDECK” on September 3, 2024. This program is part of the Deep Startup Acceleration Program (GSAP), which is developed by the Japan External Trade Organization (JETRO) together with the Cabinet Office and the Ministry of Economy, Trade and Industry.
It is positioned as a Tech course. During this program period, we plan to release the U.S. version of Atopiyo, an app for atopic dermatitis patients.
JETRO adoption URL:
https://www.jetro.go.jp/news/releases/2024/c0798b546c5eddf4.html

[US version app pre-registration form]
Those who have registered their email address will be contacted when the US version of the app (English version) is launched in 2024. Atopiyo URL: https://www.atopiyo.com

[What is Berkeley SKYDECK]
Berkeley
SKYDECK is a global startup acceleration program originating from the University of California, Berkeley, which consistently ranks at the top of various world university rankings.
This program will be a 12-week startup incubation program conducted in a hybrid format, both locally in the US and online, and we also plan to accept interns from the University of California, Berkeley. At the end of the program, a demo day will be held with over 100 investors and venture capital participants.
JETRO GSAP URL: https://www.jetro.go.jp/services/gsap.html

[What is Atopiyo?]
Atopiyo aims to support the early recovery of people suffering from atopic dermatitis, and by posting images in addition to text, Atopiyo anonymously records and shares skin symptoms, itching, and skin care unique to atopic dermatitis. This is the first app in Japan that allows you to
Check Store/Google Play).
In July 2018, Ako, a former atopic dermatitis patient,
After Ryotaro released it, it won 10 awards including the Minister of Health, Labor and Welfare Award at the 10th Let’s Extend Your Healthy Lifespan! Award sponsored by the Ministry of Health, Labor and Welfare, and as of September 2024, it has been downloaded 27,000 times and posted 60,000 photos. It has grown into one of Japan’s largest apps for atopic dermatitis patients with images. Also, App
It has a high rating of 4.5 (out of 5) from users on both the Store and Google Play.
In the field of atopic dermatitis, we are currently conducting big data analysis in collaboration with seven university hospitals and facilities, including Kyoto Prefectural University of Medicine, and promoting disease awareness in collaboration with pharmaceutical companies.
App Store URL: https://apps.apple.com/app/id1407586408
Google Play URL:
https://play.google.com/store/apps/details?id=com.atopiyo.atopiyo What is Atopiyo? – Atopiyo
[Future outlook]
It is said that there are 1.32 million atopic dermatitis patients in Japan and 31.6 million in the United States.
We will release a US version of the app in conjunction with this program, and through local feedback we will create a symptom management and community app that can be used by atopic dermatitis patients in the US. Furthermore, in the United States, we aim to create a cycle of giving back to people with atopic dermatitis by collaborating with medical and pharmaceutical companies.

[Representative/Developer Profile]
Ryotaro AKO
Former atopic dermatitis. programmer. Master of Engineering. Certified public accountant.
Due to his experience with three allergic diseases: atopic dermatitis, asthma, and rhinitis, he engaged in volunteer activities at patient groups. Ako, a pharmacist, interviews people with atopic dermatitis I developed this app by myself with Akiko’s opinion and the guidance and supervision of programmers.

[Main awards]
・Part 10: Extend your healthy lifespan! Award Minister of Health, Labor and Welfare Award (Sponsor: Ministry of Health, Labor and Welfare)
・Innovation 2020 Generation Award Special Corporate Award (Sponsor: Ministry of Internal Affairs and Communications)
・Japan Healthcare Business Contest 2020 Excellence Award/Special Award (Sponsor: Ministry of Economy, Trade and Industry)

[Operating company]
Company name: Atopiyo LLC
Address: 5-13-33 Myoden, Ichikawa City, Chiba Prefecture
Representative: Ryotaro AKO
Establishment date: March 15, 2021
Business details: Software development, information processing and information provision services, support for surveys, research, product development, and disease awareness in the field of atopic dermatitis. Company URL: https://www.atopiyo.com
TEL: 070-8932-1623
EMAIL: support@atopiyo.com






0 0 votes
Article Rating
guest
0 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
This article has been partially generated with the assistance of AI.
0
Would love your thoughts, please comment.x
()
x